This recognition is a testament to the dedication of our incredible team at Reglagene in advancing therapies for brain diseases. Watch the video to see what drives our commitment to groundbreaking solutions and the future we're building. Thank you, Arizona BioIndustry Association (AZBio)!

Reglagene’s Richard Austin was on a panel during the AZAdvances Innovation Showcase during AZBio Week.

This award underscores the critical importance of advancing brain disease product development and the need to improve patient lives. Reglagene’s commitment to groundbreaking solutions remains steadfast, and we're excited for the future!

Richard Austin and Michael Abrahamson are joined by Board Chair Lawrence Kinet, Tripp Shannon, CFA, and Jeff Koenig at Seattle’s Keiretsu Syndication Summit & Keiretsu Family Office Forum.

Dr. Richard Austin will be presenting Reglagene at the Keiretsu Family Office Forum on August 16, 2023.

Reglagene's CEO Richard Austin is attending the 2023 SNO/ASCO CNS Cancer Conference.

This step confirms the safety and pharmacological activity exhibited by a drug for commercial development and paves the way to the next step: the initiation of human clinical trials.

Reglagene is honored to announce our partnership with Tech Coast Angels.

We have an incredible opportunity to join our team for a 3 month internship.